top of page

Cleerly’s James Min talks about heart disease and improving cardiovascular imaging at #HLTH2023

Dr. Min describes how Cleerly’s technology is designed to improve how CT scans are analyzed, and how the company aims to move upstream from symptomatic disease to doing asymptomatic screening as well.

Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page